Gapping down
In reaction to disappointing earnings/guidance:
- UAA -14%, MIME -7%, GT -6.4%, ONDK -4.8%, MELI -4.6%, ELY -4.3%, RPD -4.3%, KMPR -2.7%, IIVI -2.5%, APPS -2.3% (also to acquire Mobile Posse), MOH -2.2%, CHGG -1.9% (also authorizes $500 mln stock repurchase program), EEFT -1.9%, EEFT -1.9%, MAS -1.8%, MLM -1.6%, DVA -0.9%, VRNS -0.8%, HLT -0.8%
Other news:
- XERS -12.6% (commences 6 mln share stock offering)
- WORK -6.1% (says IBM has been its largest customer for several years; no update to guidance)
- MRNA -5.3% (announces $500 mln stock offering, also announces first patient enrolled in Phase 1/2 study; also announces progress on vaccine modality)
- ADVM -4.6% (announces $100 mln stock offering)
- SLCA -2.6% (reduces quarterly dividend)
- NYMT -1.8% (prices offering 44 mln shares of common stock for gross proceeds of $269.7 mln)
Analyst comments:
- MELI -4.6% (downgraded to Neutral from Buy at Citigroup)
- EPC -2.2% (downgraded to Neutral from Buy at Citigroup)
- COR -1.7% (downgraded to Underperform from Neutral at BofA/Merrill)
- FB -0.8% (downgraded to Sell at Pivotal Research Group)